Himadri Speciality Chemical Ltd Q1 FY27 Results

Himadri's Q1 FY-2027 result is a genuine beat—revenue ₹1,432 Cr and net profit ₹228 Cr each outpaced prior-year by 28% and 27%, with margins stable at 20.1% OPM and 15.3% NPM. Yet in the earnings call, management reaffirmed the FY28 PAT target of ₹1,100 Cr without upgrading it, despite this strong organic run. That decision, combined with analyst Tanvi Warekar's sharp challenge to the LFP margin math and the MD's deflection on cost structure, reveals the real story: the company's long-term case hinges on LFP profitability at China parity pricing, and that margin economics remain unproven and opaque.

Q1's PAT ₹228 Cr is organic—no one-time MTM or exceptional items distort the headline. The profit grew 27% YoY on revenue growth of 28%, reflecting stable operational leverage and a modest product-mix upgrade. Segment-by-segment: Coal Tar Derivatives and Speciality Carbon Black remain the core (high margins, stable volumes), and Birla Tyres added ₹127 Cr in Q1 sales on the path to EBITDA breakeven in FY27. The headwind: mining operations halted awaiting environmental licensing, eliminating a prior ₹25 Cr quarterly EBIT contribution—material for Q1, but offset by Birla ramp and immaterial to the full-year PAT target (<2% of ₹1,100 Cr guidance).

The third and fourth claims are well-supported. The anode 200 MTPA facility came live in April and is actively supplying Stage B samples globally—a tangible de-risking vs. prior pilot-only status. The FY28 PAT target reaffirmation is unhedged: management said 'definitely' unchanged. But the second claim—LFP profitability at China parity—is where credibility broke. When Tanvi Warekar showed that lithium carbonate input costs plus China's current ₹[price] per tonne pricing yield a negative gross spread, the MD responded not with cost substantiation but with 'Excel sheet won't work' and 'that's confidential.' That evasion is the quarter's turning point: the bull case for ₹3,000 Cr LFP revenue by FY28 is entirely contingent on LFP margins, and the margin claim is now credibility-scarred.

The honest read: This is a Hold. Himadri is a high-quality execution machine—Q1 beat confirms that—but the bull case is a call option on two unproven claims: (1) LFP is profitable at China parity pricing, and (2) new products (CNT, SSCB, anode) scale to the forecasted revenue. On claim 1, the MD has already forfeited credibility by deflecting rather than substantiating. On claim 2, the company is guarded and vague. The capex cycle is real; if returns disappoint, FCF tightens and the ₹1,100 Cr FY28 PAT target becomes a ceiling, not a stepping stone. The market's +12% pop by day 5, now fading to ₹750.65 (8% below all-time high), reflects this: believers exist, but skeptics rightfully hold back enthusiasm until LFP margin is proven.

Price action: The result announcement (Wed Jul 15, ₹681.55 close) triggered a day-1 pop of +5.99%, which expanded to +12.96% by day 3 and held near +12.72% by day 5. The stock now trades at ₹750.65 (as of Jul 31), sitting 8.37% below its all-time high of ₹819.25. It is above its 20-day (₹724.32), 50-day (₹680.34), and 200-day (₹531.25) simple moving averages—a bullish posture. But the 8% drawdown from ATH and RSI of 66 (neutral, not overbought) suggest the market is cautiously optimistic rather than euphoric about the long-term story.

Institutional positioning: FII ownership ticked up to 5.98% (from 5.75% prior quarter, +23 bps), and DII to 3.21% (from 3.10%, +11 bps). Promoter holding remains stable at 52.50%. Both FII and DII accumulation, albeit modest, signals institutional faith in the growth roadmap. Bulk-block activity in the past 6 months shows no promoter or insider-linked selling near the highs—a green flag. The accumulation is measured, not aggressive, consistent with a story that requires proof (LFP margin validation) before conviction deepens.

Valuation context: The stock has rebounded 79.37% from its 52-week low of ₹418.50, and is 8% off ATH. In a 52-week range of ₹418.5–₹819.25, the current ₹750.65 is in the upper quartile, suggesting the market has priced in a reasonable portion of the growth upside. The pop-and-fade pattern (day-1 +6%, day 5 +13%, now -8% from peak) is textbook for a 'beat on numbers, but macro story unclear' narrative—institutions are buying the execution track record, not yet the LFP thesis.

Himadri delivered a solid Q1—no ambiguity on the 28% revenue and 27% PAT growth. The Mahistikry anode facility is live and sampling, Birla Tyres is ramping, and the capex roadmap is concrete. But this quarter is not a step-change; it's steady execution of a strategy whose profitability remains unproven. The market's +12% pop and subsequent fade to ₹750.65 (8% off ATH) is the correct reading: buy the execution track record, but wait for LFP margin proof before committing conviction. The number to track from here is not the topline—it's the FY28 PAT delivery of ₹1,100 Cr and the LFP gross margin disclosed in that result. If management delivers both, the stock reprices upward. If LFP margins disappoint (or remain opaque), the stock treads water or re-rates lower. Until that test, Hold.